Michael Wolf

Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain.

CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.

LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany.

Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom.

Part of SRH Holding (SdbR), SRH Kliniken GmbH is a healthcare company that operates multiple clinics across Germany, including locations in Gera, Karlsbad-Langensteinbach, Bad Wimpfen, Neresheim, Oberndorf a.N., Bad Kösen, and others. The company is based in Heidelberg, Germany. The company provides medical services and treatments to patients in these regions. The CEO of the company is Werner Stalla.

NewMarket Venture Verwaltungs GmbH provides management services. The private company is based in Mannheim, Germany. The German company was founded in 2000. The CEO is Christof Hettich.

RITTERSHAUS Management und Beteiligungs GmbH provides management services. The private company is based in Mannheim, Germany. The CEO of the German company is Christof Hettich.

Active Motif, Inc. develops and distributes molecular biology-based research tools and kits that help researchers elucidate the function, regulation and interactions of the genes and their encoded proteins. Its products include New TransAM, Methylated Histones, and Histone Purification Mini Kit. The company was founded in 1999 and is located in Carlsbad, CA.

SRH Holding engages in the provision of educational and health care services. It operates universities, vocational schools, vocational rehabilitation centers, acute care hospitals, rehabilitation clinics, and outpatient care centers. The company was founded in 1966 and is headquartered in Heidelberg, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Franz Haniel & Cie. GmbH is a Haniel family equity firm. The company was founded in 1756 by Jan Willem Noot and is headquartered in Duisburg, Germany.

Privatbrauerei Eichbaum GmbH & Co. KG engages in production of beers. The firm offers UREICH, classic, wheat, Wild monkeys, and Brewmaster still beers. The firm was founded on October 3, 1679 and is headquartered in Mannheim, Germany.

AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.

Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements.

Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland.

Actris Ag's develops and manages real estate properties. The firm also produces and distributes beer. The company is headquartered in Mannheim, Germany

InterComponentWare AG provides technology solutions for the healthcare market. Its products include ICW Master Patient Index, ICW Professional Exchange Server and ICW Care Manager. The firm serves the hospitals, care providers and care management companies. The company was founded in October 26, 1998 and is headquartered in Walldorf, Germany.

RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB is a law firm based in Mannheim, Germany. The German company has a unique perspective on the legal world and operates differently from traditional law firms. The private company's description emphasizes its distinctiveness and alternative approach to legal services.

dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany.

febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany.

J.F. Müller & Sohn AG manufactures hardwood veneer, softwood veneer, and plywood. The company was founded by Friedrich Jacob Müller in 1795 and is headquartered in Hamburg, Germany.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain.

Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005.